Gyomor- és nyelőcsőrák: vizsgálatok itt: Szingapúr
11 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleSubstudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 298 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06780111 · EU 2024-514273-22-00 - 1/2. fázisTaking peopleStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT04198766 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 1/2. fázisTaking peopleA Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 235 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00 - 2. fázisNot yet taking people in SzingapúrUse of Pyrvinium to Reverse Stomach Precancerous Conditions
- Where
- Singapore
- Életkor
- 21 év and over
- People
- 50
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06782048 - 1/2. fázisTaking peopleA Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05319730 · EU 2023-505189-26-00 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Bukit Merah, Singapore
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 1. fázisTaking peopleIKS014 in Advanced Solid Tumors That Express HER2
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05872295 - No phaseTaking peopleMultimodal Prehabilitation in Gastric Cancer Patients
- Where
- Singapore
- Életkor
- 22 év to 99 év
- People
- 25
- Run by
- National University Hospital, Singapore
See details and how to joinNCT07839702 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - 2. fázisTaking peopleA Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Where
- Singapore
- Életkor
- 21 év to 99 év
- People
- 360
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06422403